Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

nanoformulation of EFV

Based on

1 Articles
2011 Most recent source

Composition

1

efavirenz

EFV
Type Single Compound
Formula C14H9ClF3NO2
Role core
2

poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)

poloxamer-188 P188
Type Polymer
Formula
Role layer
3

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]

1,2-distearoyl-phosphatidylethanolamine-methyl-polyethyleneglycol conjugate-2000 mPEG2000DSPE
Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source
Zeta potential

0 more entry available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

1 more entry available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
human monocyte-derived macrophages

0 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]
  • poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
  1. jYIZVt9Nh2OGxuOMZEEk
Product

nanoformulation of EFV

Method 2

Type: Physical formation
Source:
Starting materials
  1. Idt9hnigyX0T6rrs5A5OPJ
Product

nanoformulation of EFV

Method 3

Type: Physical formation
Source:
Starting materials
  • 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]
  • poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
  1. 7uyJqs3nVsFWjJ3OKbgc
Product

nanoformulation of EFV

Method 4

Type: Physical formation
Source:
Starting materials
  1. VhxC2tnKeUMmPnziM8CQYX
Product

nanoformulation of EFV

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial